Metrics
- Price
- $31.05
- Market Cap $M
- 2,267
- Rel Volume
- 1.32
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- +62.00%
- 1D
- +4.65%
- 1W
- +7.03%
- 1M
- +32.13%
- 1M Slope
- +33.09%
- 6M Range
- 42.37%
- Score
- 70.6
- Sharp
- 4.1
Volume
Profile
Zymeworks is a clinical-stage biotech company developing multifunctional antibody-based therapeutics, especially oncology candidates designed to target multiple cancer pathways.
Biotech
Pharmaceuticals